Search results
Order by most recent / most popular / relevance
Results: 1-4 of 4
Dispelling the Myriad gene patent harmonization myth
- Foley & Lardner LLP
- -
- Australia, Canada, European Union, France, Germany, Japan, USA
- -
- April 30 2013
In the wake of the Supreme Court oral arguments in the Myriad "gene patent" case, most commentators are predicting that the Court will uphold the
Overview of patent-statutory subject matter in biotechnology
- CCPIT Patent & Trademark Law Office
- -
- China, European Union, Japan, USA
- -
- April 8 2013
With the advent of biotechnology, the human community stands on the threshold of an extraordinary revolution having profound
Protection for medical-related inventions in Japan
- Shiga International Patent Office
- -
- Japan
- -
- April 8 2013
Japan has the second largest medical market in the world. For instance, there has been active development in recent years concerning regenerative
Patent term extensions and regulatory exclusivities for pharmaceuticals in Asia and South America
- Morrison & Foerster LLP
- -
- Argentina, Brazil, Chile, China, Hong Kong, Japan, Malaysia, Mexico, Philippines, South Korea, Thailand, USA, Vietnam
- -
- June 27 2012
Patent protection for pharmaceutical products has an impact on the pharmaceutical market and innovation
Current Search
Suggested Facets
Author
Firm Name
- CCPIT Patent & Trademark Law Office (1)
- Foley & Lardner LLP (1)
- Morrison & Foerster LLP (1)
- Shiga International Patent Office (1)
